| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.24 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |